PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.45%
Net income growth above 1.5x META's 10.17%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-3.46%
Negative yoy D&A while META is 11.33%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
111.66%
Some yoy growth while META is negative at -17.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-13.09%
Negative yoy SBC while META is 16.57%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-80.63%
Both reduce yoy usage, with META at -271.20%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-344.21%
Both yoy AR lines negative, with META at -147.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-42.19%
Negative yoy inventory while META is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
174.85%
AP growth well above META's 144.49%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-11.58%
Negative yoy usage while META is 93.48%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
36.69%
Lower 'other non-cash' growth vs. META's 175.76%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
0.20%
Operating cash flow growth below 50% of META's 6.39%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-18.79%
Both yoy lines negative, with META at -27.80%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-94.26%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-6.72%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-22.69%
We reduce yoy sales while META is 198.35%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-82.88%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.